Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Neoplasm Grading"" wg kryterium: Temat


Starter badań:

Tytuł:
Impact of prostate biopsy secondary pathology review on radiotherapy management.
Autorzy:
Siedow M; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Eisner M; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Yaney A; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Washington I; Department of Radiation Oncology, Moffit Cancer Center, Tampa, Florida, USA.
Zynger D; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Martin D; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Mo X; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Diconstanzo D; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Diaz DA; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Pokaż więcej
Źródło:
The Prostate [Prostate] 2022 Feb; Vol. 82 (2), pp. 210-215. Date of Electronic Publication: 2021 Oct 26.
Typ publikacji:
Journal Article
MeSH Terms:
Biopsy*/methods
Biopsy*/standards
Neoplasm Grading*/methods
Neoplasm Grading*/standards
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/mortality
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/radiotherapy
Radiotherapy*/adverse effects
Radiotherapy*/methods
Referral and Consultation*
Prostate/*pathology
Clinical Decision-Making/methods ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Observer Variation ; Prostate-Specific Antigen/blood ; Risk Assessment ; Survival Analysis ; United States/epidemiology
Czasopismo naukowe
Tytuł:
Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer.
Autorzy:
Preisser F; Department of Urology, University Hospital Frankfurt, Frankfurt, Germany.
Würnschimmel C; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Pose RM; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Heinze A; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Steuber T; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Michl U; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Salomon G; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Mandel P; Department of Urology, University Hospital Frankfurt, Frankfurt, Germany.
Graefen M; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Pokaż więcej
Źródło:
The Prostate [Prostate] 2022 Feb; Vol. 82 (2), pp. 254-259. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Grading*/methods
Neoplasm Grading*/standards
Neoplasm Grading*/statistics & numerical data
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/surgery
Biopsy/*methods
Aged ; Correlation of Data ; Humans ; Male ; Neoplasm Recurrence, Local/pathology ; Outcome Assessment, Health Care/methods ; Predictive Value of Tests ; Prostate/pathology ; Prostate-Specific Antigen/analysis ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Prostatectomy/statistics & numerical data ; Salvage Therapy/adverse effects ; Salvage Therapy/methods ; Salvage Therapy/statistics & numerical data
Czasopismo naukowe
Tytuł:
Neuroendocrine tumor (NET) of the vagina in the light of WHO 2020 2-tiered grading system: clinicopathological report of the first described case.
Autorzy:
Inzani F; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Unità di Gineco-patologia e Patologia Mammaria, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Santoro A; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Unità di Gineco-patologia e Patologia Mammaria, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Angelico G; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Unità di Gineco-patologia e Patologia Mammaria, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Mastrosimini MG; Department of Diagnostics and Public Health, G.B. Rossi University Hospital, Verona, Italy.
Masciullo V; Division of Gynecology, Dipartimento Scienze della Salute della donna e del bambino e di Sanità pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Salutari V; Gynecologic Oncology Unit, Department of Woman, Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Zannoni GF; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Unità di Gineco-patologia e Patologia Mammaria, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. .; Istituto di Anatomia Patologica, Università Cattolica del Sacro Cuore, Rome, Italy. .; Department of Woman and Child Health, UCSC and Fondazione Policlinico Gemelli, Rome, Italy. .
Pokaż więcej
Źródło:
Virchows Archiv : an international journal of pathology [Virchows Arch] 2022 Mar; Vol. 480 (3), pp. 687-691. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Grading*
Neuroendocrine Tumors*/diagnosis
Neuroendocrine Tumors*/pathology
Vaginal Neoplasms*/diagnosis
Vaginal Neoplasms*/pathology
Biomarkers, Tumor ; Female ; Humans ; Ki-67 Antigen ; Necrosis ; Vagina/pathology ; World Health Organization
Czasopismo naukowe
Tytuł:
Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients.
Autorzy:
Buck A; Research Unit Analytical Pathology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Prade VM; Research Unit Analytical Pathology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Kunzke T; Research Unit Analytical Pathology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Feuchtinger A; Research Unit Analytical Pathology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Kröll D; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Surgery, Campus Charité Mitte/Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Feith M; Department of Surgery, Klinikum rechts der Isar, TUM School of Medicine, Munich, Germany.
Dislich B; Institute of Pathology, University of Bern, Bern, Switzerland.
Balluff B; Maastricht Multimodal Molecular Imaging Institute (M4i), Maastricht University, Maastricht, The Netherlands.
Langer R; Institute of Pathology, University of Bern, Bern, Switzerland.; Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria.
Walch A; Research Unit Analytical Pathology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Pokaż więcej
Źródło:
The Journal of pathology [J Pathol] 2022 Feb; Vol. 256 (2), pp. 202-213. Date of Electronic Publication: 2021 Dec 04.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Energy Metabolism*
Metabolome*
Metabolomics*
Neoadjuvant Therapy*/adverse effects
Neoadjuvant Therapy*/mortality
Neoplasm Grading*
Adenocarcinoma/*drug therapy
Biomarkers, Tumor/*metabolism
Esophageal Neoplasms/*drug therapy
Adenocarcinoma/metabolism ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Chemoradiotherapy, Adjuvant ; Chemotherapy, Adjuvant ; Esophageal Neoplasms/metabolism ; Esophageal Neoplasms/mortality ; Esophageal Neoplasms/pathology ; Esophagectomy ; Germany ; Humans ; Machine Learning ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Switzerland ; Time Factors ; Treatment Outcome
SCR Disease Name:
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Tytuł:
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients.
Autorzy:
Seyrek N; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Radiology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hollemans E; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Osanto S; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
Pelger RCM; Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands.
van der Poel HG; Department of Urology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bekers E; Department of Pathology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bangma CH; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Rietbergen J; Department of Urology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Schoots IG; Department of Radiology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van Leenders GJLH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Feb; Vol. 80 (3), pp. 558-565. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Grading*
Prognosis*
Adenocarcinoma/*pathology
Prostatic Neoplasms/*pathology
Carcinoma, Intraductal, Noninfiltrating/pathology ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prostatectomy
Czasopismo naukowe
Tytuł:
Clinical experience and treatment approaches in sinonasal osteomas from a Tertiary Care Hospital in Turkey.
Autorzy:
Değer HM; Department of Otorhinolaryngology, Faculty of Medicine Kocaeli University, Kocaeli, Turkey.
Bayrak BY; Department of Pathology, Faculty of Medicine Kocaeli University Faculty of Medicine, Kocaeli, Turkey. Electronic address: .
Mutlu F; Department of Otorhinolaryngology, Faculty of Medicine Kocaeli University, Kocaeli, Turkey.
Öztürk M; Department of Otorhinolaryngology, Faculty of Medicine Kocaeli University, Kocaeli, Turkey.
Pokaż więcej
Źródło:
Auris, nasus, larynx [Auris Nasus Larynx] 2022 Feb; Vol. 49 (1), pp. 84-91. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Grading*/methods
Osteoma/*pathology
Otorhinolaryngologic Surgical Procedures/*methods
Paranasal Sinus Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Endoscopy ; Female ; Humans ; Male ; Middle Aged ; Osteoma/diagnostic imaging ; Osteoma/surgery ; Paranasal Sinus Neoplasms/diagnostic imaging ; Paranasal Sinus Neoplasms/surgery ; Retrospective Studies ; Tertiary Care Centers ; Tomography, X-Ray Computed ; Turkey
Czasopismo naukowe
Tytuł:
Osteolytic or mixed bone metastasis is not uncommon in patients with high-risk prostate cancer.
Autorzy:
Kurokawa R; Department of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Electronic address: .
Kato S; Department of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Koyama H; Department of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Ishida M; Department of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Kurokawa M; Department of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Kuroda R; Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Ushiku T; Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Kume H; Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Abe O; Department of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Pokaż więcej
Źródło:
European journal of radiology [Eur J Radiol] 2022 Dec; Vol. 157, pp. 110595. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Neoplasms*/diagnostic imaging
Bone Neoplasms*/secondary
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Male ; Humans ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Prostate-Specific Antigen ; Neoplasm Grading ; Lymphatic Metastasis
Czasopismo naukowe
Tytuł:
Is Gleason 6 cancer? The answer is more than just a 'name'.
Autorzy:
Wilt TJ; Minneapolis VA Center for Care Delivery and Outcomes Research, Minneapolis, MN, USA.; Lisa Schwarz Foundation for Truth in Medicine, Norwich, VT, USA.
Dahm P; Minneapolis VA Healthcare System and the University of Minnesota Department of Urology, Minneapolis, MN, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Dec; Vol. 130 (6), pp. 704-705.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Neoplasms*
Humans ; Neoplasm Grading
Opinia redakcyjna
Tytuł:
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens.
Autorzy:
Martini A; Department of Urology, La Croix du Sud Hospital, 52, Chemin de Ribaute, 31130, Quint Fonsegrives, France.; IUCT-O, Toulouse, France.
Touzani A; Department of Urology, La Croix du Sud Hospital, 52, Chemin de Ribaute, 31130, Quint Fonsegrives, France. .; IUCT-O, Toulouse, France. .
Beauval JB; Department of Urology, La Croix du Sud Hospital, 52, Chemin de Ribaute, 31130, Quint Fonsegrives, France.; IUCT-O, Toulouse, France.
Ruffion A; Service d'urologie Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.; Equipe 2, Centre d'Innovation en Cancérologie de Lyon (EA 3738 CICLY), Faculté de Médecine Lyon Sud, Université Lyon 1, Lyon, France.
Olivier J; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.
Gasmi A; Department of Urology, CHU Rennes, Rennes, France.
Dariane C; Department of Urology, Hôpital Européen Georges-Pompidou, APHP, Paris-Paris University-U1151 Inserm-INEM, Necker, Paris, France.
Thoulouzan M; Department of Urology, CHU Toulouse, Toulouse, France.
Barret E; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
Brureau L; CHU de Pointe-À-Pitre, University of Antilles, University of Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement Et Travail)-UMR_S 1085, 97110, Pointe-À-Pitre, France.
Créhange G; Department of Radiotherapy, Institut Curie, Paris, France.
Fiard G; Department of Urology, Grenoble Alpes University Hospital, Université Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, Grenoble, France.
Gauthé M; Unité de Recherche Clinique en Économie de la Santé, CRESS METHODS INSERM UMR 1153, Paris, France.
Renard-Penna R; Sorbonne University, AP-HP, Radiology, Pitie-Salpetriere Hospital, F-75013, Paris, France.
Roubaud G; Department of Medical Oncology, Institut Bergonié, 33000, Bordeaux, France.
Sargos P; Department of Radiotherapy, Institut Bergonié, 33000, Bordeaux, France.
Roumiguié M; Department of Urology, CHU Toulouse, Toulouse, France.
Timsit MO; Department of Urology, Hôpital Européen Georges-Pompidou, APHP, Paris-Paris University-U1151 Inserm-INEM, Necker, Paris, France.
Mathieu R; Department of Urology, CHU Rennes, Rennes, France.
Villers A; Department of Urology, Univ. Lille, CHU Lille, 59000, Lille, France.
Rouprêt M; Sorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitie-Salpetriere Hospital, 75013, Paris, France.
Fromont G; Department of Pathology, CHRU Tours, Tours, France.
Ploussard G; Department of Urology, La Croix du Sud Hospital, 52, Chemin de Ribaute, 31130, Quint Fonsegrives, France.
Pokaż więcej
Corporate Authors:
CC-AFU, Cancerology Committee of the Association Française d’Urologie
Źródło:
World journal of urology [World J Urol] 2022 Dec; Vol. 40 (12), pp. 2931-2937. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Prostatectomy ; Neoplasm Grading ; Prostate/pathology ; Margins of Excision ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Tytuł:
A multitask classification framework based on vision transformer for predicting molecular expressions of glioma.
Autorzy:
Xu Q; Department of Radiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou City, Jiangsu Province 221002, China.
Xu QQ; School of Medical Information and Engineering, Xuzhou Medical University, Xuzhou City, Jiangsu Province 221002, China.
Shi N; School of Medical Imaging, Xuzhou Medical University, Xuzhou City, Jiangsu Province 221002, China.
Dong LN; Department of Radiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou City, Jiangsu Province 221002, China.
Zhu H; School of Medical Information and Engineering, Xuzhou Medical University, Xuzhou City, Jiangsu Province 221002, China. Electronic address: .
Xu K; Department of Radiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou City, Jiangsu Province 221002, China. Electronic address: .
Pokaż więcej
Źródło:
European journal of radiology [Eur J Radiol] 2022 Dec; Vol. 157, pp. 110560. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Glioma*/diagnostic imaging
Humans ; Isocitrate Dehydrogenase/genetics ; Ki-67 Antigen ; Tumor Suppressor Protein p53 ; Neoplasm Grading ; Mutation ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Tytuł:
Significance of non-standardized magnetic resonance imaging abnormalities and subsequent targeted prostate cancer biopsy for pathologists: A retrospective observational study.
Autorzy:
Okubo Y; Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. Electronic address: .
Yamamoto Y; Department of Radiology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Terao H; Department of Urology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Suzuki T; Department of Urology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Koizumi M; Department of Urology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Yoshioka E; Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Washimi K; Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Sato S; Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Yokose T; Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Kishida T; Department of Urology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Miyagi Y; Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2022 Dec; Vol. 240, pp. 154188. Date of Electronic Publication: 2022 Oct 26.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Prostatic Neoplasms*/pathology
Magnetic Resonance Imaging, Interventional*/methods
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/pathology
Male ; Humans ; Prostate/pathology ; Magnetic Resonance Imaging ; Pathologists ; Ultrasonography, Interventional/methods ; Image-Guided Biopsy/methods ; Neoplasm Grading
Czasopismo naukowe
Tytuł:
Ultrasonographic pathological grading of prostate cancer using automatic region-based Gleason grading network.
Autorzy:
Lu X; Guangdong Polytechnic Normal University, Guangzhou 510665, China; Pazhou Lab, Guangzhou 510330, China.
Zhang S; Guangdong Polytechnic Normal University, Guangzhou 510665, China.
Liu Z; Guangdong Polytechnic Normal University, Guangzhou 510665, China.
Liu S; Guangdong Polytechnic Normal University, Guangzhou 510665, China.
Huang J; Department of Ultrasonography, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Kong G; Department of Ultrasonography, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Li M; Department of Ultrasonography, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Liang Y; Department of Ultrasonography, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Cui Y; Department of Radiology, Foshan Maternity and Children's Healthcare Hospital Affiliated to Southern Medical University, Foshan 528000, China.
Yang C; Department of Ultrasonography, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China. Electronic address: .
Zhao S; Department of Artificial Intelligence, Sun Yat-sen University, Guangzhou 510006, China. Electronic address: .
Pokaż więcej
Źródło:
Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society [Comput Med Imaging Graph] 2022 Dec; Vol. 102, pp. 102125. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji:
Journal Article
MeSH Terms:
Image Interpretation, Computer-Assisted*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Male ; Humans ; Neoplasm Grading ; Neural Networks, Computer
Czasopismo naukowe
Tytuł:
Impact of tumor grade on pancreatic neuroendocrine tumors.
Autorzy:
Shyr BS; Division of General Surgery, Departments of Surgery, Taipei Veterans General Hospital, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Shyr BU; Division of General Surgery, Departments of Surgery, Taipei Veterans General Hospital, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Chen SC; Division of General Surgery, Departments of Surgery, Taipei Veterans General Hospital, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Shyr YM; Division of General Surgery, Departments of Surgery, Taipei Veterans General Hospital, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Wang SE; Division of General Surgery, Departments of Surgery, Taipei Veterans General Hospital, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC. Electronic address: .
Pokaż więcej
Źródło:
Asian journal of surgery [Asian J Surg] 2022 Dec; Vol. 45 (12), pp. 2659-2663. Date of Electronic Publication: 2022 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroendocrine Tumors*/pathology
Pancreatic Neoplasms*/pathology
Humans ; Male ; Infant, Newborn ; Retrospective Studies ; Prognosis ; Neoplasm Grading
Czasopismo naukowe
Tytuł:
Calibrated Regression Models Based on the Risk of Clinical Nodal Metastasis Should be Used as Decision Aids for Prostate Cancer Staging to Reduce Unnecessary Imaging.
Autorzy:
Hayes M; Department of Urology, Oregon Health and Science University, Portland, OR, USA. Electronic address: .
Yu Y; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Bassale S; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Chakiryan N; Department of Urology, Moffitt Cancer Center, Tampa, FL, USA.
Chen Y; Biometrics, Seagen, Inc., Bothell, WA, USA.
Ye S; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Garzotto M; Department of Urology, Oregon Health and Science University, Portland, OR, USA; Urology Section, VA Portland Healthcare System, Portland, OR, USA.
Kopp R; Department of Urology, Oregon Health and Science University, Portland, OR, USA; Urology Section, VA Portland Healthcare System, Portland, OR, USA.
Pokaż więcej
Źródło:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2022 Dec; Vol. 20 (6), pp. e490-e497. Date of Electronic Publication: 2022 May 07.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Male ; Humans ; Neoplasm Grading ; Magnetic Resonance Imaging/methods ; Biopsy ; Decision Support Techniques ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Necrosis is an independent predictor of disease-free and overall survival in pancreatic well-differentiated neuroendocrine tumours (NETs): a proposal to include it in grading systems.
Autorzy:
Fuchs TL; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia; Douglass Hanly Moir, Macquarie Park, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia. Electronic address: .
Chou A; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia.
Ahadi M; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia.
Sheen A; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia.
Sioson L; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia.
Mittal A; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Upper GI Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, St Leonards, NSW, Australia; Australian Pancreatic Centre, St Leonards, NSW, Australia; University of Notre Dame, Darlinghurst, NSW, Australia.
Samra J; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Upper GI Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, St Leonards, NSW, Australia; Australian Pancreatic Centre, St Leonards, NSW, Australia.
Gill AJ; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia.
Pokaż więcej
Źródło:
Pathology [Pathology] 2022 Dec; Vol. 54 (7), pp. 855-862. Date of Electronic Publication: 2022 Jul 13.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroendocrine Tumors*/pathology
Pancreatic Neoplasms*/pathology
Humans ; Ki-67 Antigen/metabolism ; Disease-Free Survival ; Neoplasm Grading ; Prognosis ; Necrosis
Czasopismo naukowe
Tytuł:
MRI-Based Computer-Aided Diagnostic Model to Predict Tumor Grading and Clinical Outcomes in Patients With Soft Tissue Sarcoma.
Autorzy:
Yang Y; Department of Pediatric Surgery, West China Hospital, Sichuan University, No. 17 People's South Road, Chengdu, Sichuan, 610041, China.
Zhou Y; Department of Pediatric Surgery, West China Hospital, Sichuan University, No. 17 People's South Road, Chengdu, Sichuan, 610041, China.
Zhou C; Department of Pediatric Surgery, West China Hospital, Sichuan University, No. 17 People's South Road, Chengdu, Sichuan, 610041, China.
Zhang X; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Guoxue Road 37, Chengdu, 610041, China.
Ma X; Department of Biotherapy and Cancer Center, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Guoxue Road 37, Chengdu, 610041, China.
Pokaż więcej
Źródło:
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2022 Dec; Vol. 56 (6), pp. 1733-1745. Date of Electronic Publication: 2022 Mar 18.
Typ publikacji:
Journal Article
MeSH Terms:
Soft Tissue Neoplasms*/diagnostic imaging
Soft Tissue Neoplasms*/pathology
Sarcoma*/diagnostic imaging
Sarcoma*/pathology
Humans ; Female ; Male ; Adult ; Neoplasm Grading ; Retrospective Studies ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Tytuł:
Tumor doubling time as preoperative predictor of malignancy and recurrence in newly diagnosed meningioma.
Autorzy:
Miwa Y; Department of Neurosurgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Sugawara T; Department of Neurosurgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. .
Kobayashi D; Department of Human Pathology, Tokyo Medical and Dental University, Tokyo, Japan.
Maehara T; Department of Neurosurgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Pokaż więcej
Źródło:
Neurosurgical review [Neurosurg Rev] 2022 Dec; Vol. 45 (6), pp. 3683-3687. Date of Electronic Publication: 2022 Sep 22.
Typ publikacji:
Journal Article
MeSH Terms:
Meningeal Neoplasms*/diagnosis
Meningeal Neoplasms*/surgery
Meningeal Neoplasms*/pathology
Meningioma*/diagnosis
Meningioma*/surgery
Meningioma*/pathology
Humans ; Ki-67 Antigen/analysis ; Magnetic Resonance Imaging ; Neoplasm Recurrence, Local/surgery ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Retrospective Studies ; Neoplasm Grading
Czasopismo naukowe
Tytuł:
Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue.
Autorzy:
Andolfi C; Section of Urology, Department of Surgery, The University of Chicago, Chicago, IL.
Vickers AJ; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: .
Cooperberg MR; Department of Urology, University of California San Francisco, San Francisco, CA; Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA.
Carroll PR; Department of Urology, University of California San Francisco, San Francisco, CA.
Cowan JE; Department of Urology, University of California San Francisco, San Francisco, CA.
Paner GP; Department of Pathology, The University of Chicago, Chicago, IL.
Helfand BT; Department of Urology, NorthShore University, Evanston, IL.
Liauw SL; Department of Radiation Oncology, The University of Chicago, Chicago, IL.
Eggener SE; Section of Urology, Department of Surgery, The University of Chicago, Chicago, IL.
Pokaż więcej
Źródło:
Urology [Urology] 2022 Dec; Vol. 170, pp. 154-160. Date of Electronic Publication: 2022 Aug 17.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms*/surgery
Male ; Humans ; Prostate ; Neoplasm Grading ; Prostatectomy
Czasopismo naukowe
Tytuł:
Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
Autorzy:
Guo H; Department of Radiology, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan, 410011, China.
Liu J; Department of Radiology, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan, 410011, China.; Department of Radiology Quality Control Center, Hunan Province, Changsha, 410011, China.
Hu J; Department of Radiology, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan, 410011, China.
Zhang H; MR Scientific Marketing, Siemens Healthineers Ltd., Wuhan, 430071, China.
Zhao W; Department of Radiology, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan, 410011, China.
Gao M; Department of Radiology, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan, 410011, China.
Zhang Y; Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, Zhejiang, China.
Yang G; Shanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic, East China Normal University, Shanghai, China.
Cui Y; Department of Neurosurgery, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Rd, Changsha, Hunan Province, 410011, P.R. China.
Pokaż więcej
Źródło:
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2022 Dec; Vol. 56 (6), pp. 1834-1844. Date of Electronic Publication: 2022 Apr 30.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/diagnostic imaging
Glioma*/genetics
Glioma*/pathology
Male ; Female ; Humans ; Adult ; Middle Aged ; Aged ; Isocitrate Dehydrogenase/genetics ; Protons ; Amides ; Prospective Studies ; Magnetic Resonance Imaging/methods ; Mutation ; Diffusion Magnetic Resonance Imaging/methods ; Neoplasm Grading
Czasopismo naukowe
Tytuł:
Low-grade prostate cancer should still be labelled cancer.
Autorzy:
Iczkowski KA; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
Molina M; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
Egevad L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Bostwick DG; Bostwick Laboratories, a division of Poplar Healthcare, Orlando, FL, USA.
van Leenders GJLH; Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
La Rosa FG; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
van der Kwast T; Laboratory Medicine Program, University Health Network and Princess Margaret Cancer Center, Toronto, ON, Canada.
Berney DM; Department of Pathology, Barts Health NHS TRUST, London, UK.
Evans AJ; Department of Pathology, Mackenzie Health, Richmond Hill, ON, Canada.
Wheeler TM; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.
Leite KRM; Urology Department, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Samaratunga H; Department of Pathology, University of Queensland School of Medicine, and Aquesta Uropathology, Toowong, QLD, Australia.
Srigley J; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Varma M; Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK.
Tsuzuki T; Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan.
Lucia MS; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Crawford ED; Department of Urology, University of California San Diego, San Diego, CA, USA.
Harris RG; UroPartners, Melrose Park, IL, USA.
Stricker P; Department of Urology, St. Vincent's Private Hospital and Clinic, Melbourne, Vic., Australia.
Lawrentschuk N; Urology Department of the Royal Melbourne Hospital and University of Melbourne, Melbourne, Vic., Australia.
Woo HH; College of Health and Medicine, Australian National University and SAN Prostate Centre of Excellence, Sydney Adventist Hospital, Sydney, NSW, Australia.
Fleshner NE; Division of Urology, University of Toronto, Toronto, ON, Canada.
Shore ND; Atlantic Urology Clinics, Myrtle Beach, NC, USA.
Yaxley J; Wesley Medical Center, Auchenflower, QLD, Australia.
Bratt O; Department of Urology and Clinical Cancer Epidemiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenberg, Gothenberg, Sweden.
Wiklund P; Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Solna, Sweden.; Department of Urology, Icahn School of Medicine, Mount Sinai, NY, USA.
Roberts M; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
Cheng L; Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN, USA.
Delahunt B; Pathology and Molecular Medicine, University of Otago, Wellington, New Zealand.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Dec; Vol. 130 (6), pp. 741-743. Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:
Letter
MeSH Terms:
Prostate*
Prostatic Neoplasms*/surgery
Male ; Humans ; Neoplasm Grading ; Prostatectomy
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz